Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386688322> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W4386688322 endingPage "1857" @default.
- W4386688322 startingPage "1849" @default.
- W4386688322 abstract "The five-year update data from the KEYNOTE-407 study have unveiled noteworthy improvements in survival outcomes achieved with pembrolizumab plus chemotherapy (Pembro+Chemo) compared to placebo plus chemotherapy (Placebo+Chemo) for patients with previously untreated metastatic squamous non-small cell lung cancer (NSCLC). Building upon this finding, our study sought to evaluate the cost-effectiveness of Pembro+Chemo, utilizing the latest available data, from the perspective of the Chinese health care system.A Markov model was employed to compare the quality-adjusted life-year (QALY), life-year (LY), total cost, and incremental cost-effectiveness ratio (ICER) between Pembro+Chemo and Placebo+Chemo. The clinical and safety data were derived from the five-year update date of the KEYNOTE-407 study. Sensitivity analyses were conducted to assess the uncertainty of the model, and additional subgroup analyses were performed to explore specific subpopulations.For patients with previously untreated metastatic squamous NSCLC, the utilization of Pembro+Chemo resulted in a improvement of 0.61 quality-adjusted life years (QALYs) along with a cost reduction of $17,491.52 when compared to Placebo+Chemo. Notably, across various subgroups with different tumor proportion scores (TPS), Pembro+Chemo demonstrated enhanced QALYs and lower total costs.From the perspective of the Chinese health care system, first-line Pembro+Chemo emerges as a dominant treatment option over Placebo+Chemo for the treatment of metastatic squamous NSCLC." @default.
- W4386688322 created "2023-09-13" @default.
- W4386688322 creator A5023779644 @default.
- W4386688322 creator A5064425810 @default.
- W4386688322 creator A5067681000 @default.
- W4386688322 creator A5081844561 @default.
- W4386688322 creator A5083170187 @default.
- W4386688322 date "2023-09-01" @default.
- W4386688322 modified "2023-09-26" @default.
- W4386688322 title "Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer in China" @default.
- W4386688322 cites W1953677527 @default.
- W4386688322 cites W2001063777 @default.
- W4386688322 cites W2122664355 @default.
- W4386688322 cites W2519603001 @default.
- W4386688322 cites W2527905628 @default.
- W4386688322 cites W2635951006 @default.
- W4386688322 cites W2753529762 @default.
- W4386688322 cites W2796582438 @default.
- W4386688322 cites W2803482512 @default.
- W4386688322 cites W2892640821 @default.
- W4386688322 cites W2908902360 @default.
- W4386688322 cites W2925446385 @default.
- W4386688322 cites W3081464123 @default.
- W4386688322 cites W3100650313 @default.
- W4386688322 cites W3192493086 @default.
- W4386688322 cites W3206806235 @default.
- W4386688322 cites W4211059596 @default.
- W4386688322 cites W4248178819 @default.
- W4386688322 cites W4286698642 @default.
- W4386688322 cites W4291670417 @default.
- W4386688322 cites W4293102128 @default.
- W4386688322 cites W4308900349 @default.
- W4386688322 cites W4319068412 @default.
- W4386688322 cites W4361004666 @default.
- W4386688322 doi "https://doi.org/10.2147/rmhp.s429394" @default.
- W4386688322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37719688" @default.
- W4386688322 hasPublicationYear "2023" @default.
- W4386688322 type Work @default.
- W4386688322 citedByCount "0" @default.
- W4386688322 crossrefType "journal-article" @default.
- W4386688322 hasAuthorship W4386688322A5023779644 @default.
- W4386688322 hasAuthorship W4386688322A5064425810 @default.
- W4386688322 hasAuthorship W4386688322A5067681000 @default.
- W4386688322 hasAuthorship W4386688322A5081844561 @default.
- W4386688322 hasAuthorship W4386688322A5083170187 @default.
- W4386688322 hasBestOaLocation W43866883221 @default.
- W4386688322 hasConcept C121608353 @default.
- W4386688322 hasConcept C126322002 @default.
- W4386688322 hasConcept C142724271 @default.
- W4386688322 hasConcept C143998085 @default.
- W4386688322 hasConcept C204787440 @default.
- W4386688322 hasConcept C27081682 @default.
- W4386688322 hasConcept C2776256026 @default.
- W4386688322 hasConcept C2776694085 @default.
- W4386688322 hasConcept C2777701055 @default.
- W4386688322 hasConcept C2780057760 @default.
- W4386688322 hasConcept C535046627 @default.
- W4386688322 hasConcept C71924100 @default.
- W4386688322 hasConceptScore W4386688322C121608353 @default.
- W4386688322 hasConceptScore W4386688322C126322002 @default.
- W4386688322 hasConceptScore W4386688322C142724271 @default.
- W4386688322 hasConceptScore W4386688322C143998085 @default.
- W4386688322 hasConceptScore W4386688322C204787440 @default.
- W4386688322 hasConceptScore W4386688322C27081682 @default.
- W4386688322 hasConceptScore W4386688322C2776256026 @default.
- W4386688322 hasConceptScore W4386688322C2776694085 @default.
- W4386688322 hasConceptScore W4386688322C2777701055 @default.
- W4386688322 hasConceptScore W4386688322C2780057760 @default.
- W4386688322 hasConceptScore W4386688322C535046627 @default.
- W4386688322 hasConceptScore W4386688322C71924100 @default.
- W4386688322 hasLocation W43866883221 @default.
- W4386688322 hasLocation W43866883222 @default.
- W4386688322 hasOpenAccess W4386688322 @default.
- W4386688322 hasPrimaryLocation W43866883221 @default.
- W4386688322 hasRelatedWork W2055244776 @default.
- W4386688322 hasRelatedWork W2348529436 @default.
- W4386688322 hasRelatedWork W2390152934 @default.
- W4386688322 hasRelatedWork W2413020017 @default.
- W4386688322 hasRelatedWork W2796582438 @default.
- W4386688322 hasRelatedWork W2894792775 @default.
- W4386688322 hasRelatedWork W2948845624 @default.
- W4386688322 hasRelatedWork W3180083804 @default.
- W4386688322 hasRelatedWork W4247922271 @default.
- W4386688322 hasRelatedWork W4255240967 @default.
- W4386688322 hasVolume "Volume 16" @default.
- W4386688322 isParatext "false" @default.
- W4386688322 isRetracted "false" @default.
- W4386688322 workType "article" @default.